ArticleActa neurologica Belgica2026

Correction: Reversible posterior leukoencephalopathy syndrome (RPLS) in a patient with chronic lymphocytic leukemia (CLL) treated with Acalabrutinib, a Bruton's tyrosine kinase (BTK) inhibitor: a case report.

Lise Janssens et al.PubMed ↗Publisher ↗

No numbers read from the abstract.